Health
Why is the market design for innovative pharmaceuticals not well understood?
That is the title of a fantastic editorial from Olivença et al. (2024). A lot of people when they look at pharmaceutical prices...
Providence Health Plan, American Heart Association Launch Cardiovascular Health Initiative
Providence Health Plan and the American Heart Association will create blood pressure programs in 20 community organizations and clinics over three years. The...
Timothy Parducci Goes Beyond the Job to Keep People Safe
Timothy Parducci joined Crothall as a housekeeper one year ago and had never worked in healthcare. But his common-sense approach to solving problems...
How Does a Housekeeper Make A Difference – Sonia Benitez’s Story
Former EVS Director Nicholas Sheets says Sonia Benitez simply embodies the best of EVS. As proof, here is a story he says he...
World Cerebral Palsy Day 2024
World Cerebral Palsy Day, celebrated annually on October 6th, is a global movement dedicated to raising awareness and promoting the rights of people...
What is Female to male surgery cost in India
We understand that you want to know about the female to male surgery cost in India to get affordable treatment. People who want...
Roche Welcomes FDA Approvals for Injectable Versions of MS and Cancer Drugs
Roche’s Tecentriq Hybreza is a subcutaneously injectable formulation of the cancer drug Tecentriq while Ocrevus Zunovo is an injectable version of multiple sclerosis...
Breast Cancer Awareness Month 2024
Every October, the world comes together to raise awareness about breast cancer, a disease that affects millions of lives worldwide. Breast cancer awareness...
Does PBM Market Share Vary by Payer Type?
A paper by Qato et al. (2024) quantifies the degree of of pharmacy benefit manager (PBM) market concentration. Across all payer types, the...
3 Biotech IPOs, $703M Raised for Clinical Trials in Cancer, Immunology & Endocrine Disorders
Bicara Therapeutics’ IPO raised $315 million raised for Phase 3 testing of a bifunctional antibody drug with potential to become a first-line treatment...
